Press Release

North America Recombinant Cell Culture Supplements Market to Grow with a CAGR of 9.44% through 2028

Increase in the Demand for Biopharmaceuticals and increase in the aging population is expected to drive the North America Recombinant Cell Culture Supplements Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “North America Recombinant Cell Culture Supplements Market – Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the North America Recombinant Cell Culture Supplements Market stood at USD 193.31 billion in 2022 and is anticipated to grow with a CAGR of 9.44% in the forecast period, 2024-2028. The awareness among individuals regarding Recombinant Cell Culture Supplements has led to favorable market conditions for the North America Recombinant Cell Culture Supplements market. Several factors contribute to the growth of various Recombinant Cell Culture Supplements products.

The North America Recombinant Cell Culture Supplements Market is significantly driven by the increasing demand for biopharmaceuticals, which encompass monoclonal antibodies, vaccines, and gene therapies. These biopharmaceuticals are gaining prominence due to their proven effectiveness in treating a wide range of diseases. This heightened demand is primarily fueled by factors such as an aging population, the growing prevalence of chronic illnesses, and the escalating need for innovative healthcare solutions. As biopharmaceutical production heavily relies on recombinant cell culture supplements to facilitate cell growth and protein expression, the market for these supplements is experiencing substantial growth. Biopharmaceutical companies and contract manufacturing organizations (CMOs) are increasingly dependent on the consistent quality of culture supplements to enhance and streamline their production processes, thereby contributing significantly to the market's expansion.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "North America Recombinant Cell Culture Supplements Market.

 

There is an increasing demand for cell culture supplements that are free from animal-derived components and precisely defined chemically. This trend arises from concerns related to the potential transmission of animal-borne diseases, batch-to-batch variability, and the need for greater control and reproducibility in cell culture processes, which will further fuel market growth. Also, to meet the specific requirements of biopharmaceutical production, manufacturers of cell culture supplements are innovating and customizing their products. This includes developing specialized media and supplements optimized for the growth and expression of specific cell lines used in biopharmaceutical manufacturing.

In June 2023, Merck KGaA announced the expansion of its facility in Lenexa, Kansas, USA. The expansion will add 9,100 square meters of lab space and is expected to create 100 new jobs. The expanded facility will be used to support Merck KGaA's growing life science business in North America.

The growing demand for biopharmaceuticals necessitates larger-scale production, often involving mammalian cell culture systems. Recombinant cell culture supplements, such as growth factors, media, and serum alternatives, are vital for supporting cell growth and protein expression during biopharmaceutical production.

In today's fast-paced world, In the race to develop new drugs and therapies, time is a critical factor. Recombinant cell culture supplements play a pivotal role in accelerating the production of therapeutic proteins, monoclonal antibodies, vaccines, and gene therapies for biopharmaceutical companies. This acceleration translates into faster drug development, more efficient clinical trials, and, ultimately, swifter access to life-saving treatments for patients. The utilization of top-notch cell culture supplements is instrumental in optimizing cell growth and protein expression, leading to increased yields and shortened production cycles. This heightened productivity empowers companies to promptly address market demands with greater efficiency. In the realm of scientific exploration, where rapid progress is essential, researchers depend on recombinant cell culture supplements for cultivating cells and conducting experiments. These supplements create the essential environment for studying disease mechanisms, crafting novel therapies, and achieving groundbreaking discoveries across various scientific and medical disciplines. Furthermore, recombinant cell culture supplements offer a valuable advantage by being customizable to align with specific cell lines, applications, and research objectives. This adaptability equips both researchers and biopharmaceutical companies with the agility needed to swiftly respond to evolving project requirements and shifting market dynamics. In a fiercely competitive landscape, ensuring product quality stands as a paramount consideration. High-caliber cell culture supplements undergo rigorous quality control measures, guaranteeing unwavering consistency and reliability. This consistent quality assurance is indispensable for achieving reproducible results and maintaining regulatory compliance throughout the drug development and manufacturing processes.

The growing awareness among consumers regarding health and wellness has shifted the focus towards the ideology of "prevention is better than cure." As a result, more individuals are relying on nutraceuticals, functional foods, and dietary and Recombinant Cell Culture Supplements to lead a healthy and disease-free life.

In recent times, Recombinant cell culture supplements are integral in the production of biopharmaceuticals such as monoclonal antibodies, vaccines, gene therapies, and recombinant proteins. They provide the necessary nutrients, growth factors, and culture media to support the growth and expression of cells used in biomanufacturing. The production of vaccines, especially viral vaccines and subunit vaccines, relies on cell culture techniques. Recombinant supplements are used to cultivate host cells and produce viral antigens or subunits for vaccine formulation. The demand for mAbs in therapeutic applications is growing. Recombinant supplements are essential for optimizing cell lines used in mAb production, resulting in higher yields and improved product quality. However, the High Cost of Production of complex biotechnological processes may hinder market growth. Moreover, challenges related to Regulatory Hurdles and Compliance and Supply Chain Vulnerabilities may pose obstacles to the Recombinant Cell Culture Supplements market in the near future.

The North America Recombinant Cell Culture Supplements Market is segmented into product, application, expression system, end-user, regional distribution, and company.

Based on its product, the Recombinant growth factors segment emerged as the dominant player in the North America market for Recombinant Cell Culture Supplements in 2022. This segment plays a pivotal role in supporting cell growth, proliferation, and protein expression, making it a critical component in various biopharmaceutical and biotechnology applications. Consequently, Recombinant growth factors, such as various types of cytokines and growth-promoting proteins, are indispensable for promoting cell proliferation and ensuring cell viability in vitro. These factors mimic the natural cellular environment, facilitating the growth of mammalian cells, including those used in the production of biopharmaceuticals. Growth factors play a vital role in enhancing the expression of recombinant proteins in cell cultures. They stimulate cells to produce more proteins, including therapeutic proteins and antibodies, which are crucial for the biopharmaceutical industry.

Based on region, United States segment is expected to grow during the forecast period.  The United States is the largest economy in North America and a North America leader in the biopharmaceutical industry. Its economic strength, robust healthcare infrastructure, and significant investments in healthcare and life sciences contribute to its dominance in the market. The U.S. is home to a large number of biotechnology and pharmaceutical companies, including major players in the biopharmaceutical sector. These companies drive the demand for cell culture supplements due to their extensive biomanufacturing operations. The U.S. hosts numerous research institutions, universities, and academic centers engaged in biopharmaceutical research and development. These organizations require cell culture supplements for their studies and often collaborate with industry players. The U.S. has a well-established and rigorous regulatory framework for biopharmaceuticals. Compliance with regulatory standards, such as Good Manufacturing Practices (GMP), necessitates the use of high-quality cell culture supplements.

The Canada market is poised to be the fastest-growing market, offering lucrative growth opportunities for Recombinant Cell Culture Supplements players during the forecast period. Factors such as Canada's biopharmaceutical sector is experiencing growth, with a rising number of biotech startups, research collaborations, and investments in biomanufacturing facilities. The Canadian government offers incentives, grants, and support for biopharmaceutical research and development. These initiatives encourage innovation and contribute to market growth. Canada has a well-educated and skilled workforce in the life sciences sector, attracting international companies and fostering local biopharmaceutical growth. Canada's strategic location provides easy access to both North American and international markets, making it an attractive destination for biopharmaceutical manufacturing. Canada often collaborates with U.S. biotech firms and research institutions, further boosting its biopharmaceutical activities.

 

Major companies operating in North America Recombinant Cell Culture Supplements Market are:

  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Corning Incorporated
  • FUJIFILM Irvine Scientific, Inc.
  • Lonza Group AG
  • Novus Biologicals, LLC
  • BBI Solutions OEM Limited
  • Gemini Bioproducts, LLC

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The advances in personalized medicine and increasing Prevalence of Chronic Diseases are key drivers of the Recombinant Cell Culture Supplements market. In recent years, The demographic shift toward an aging population increases the prevalence of chronic diseases and age-related conditions. Biopharmaceuticals are often used to address these health challenges, driving the demand for cell culture supplements. Moreover, the growing consumer emphasis on preventative healthcare products has enhanced production and marketing efforts. To meet the demands of the market, manufacturers are increasingly incorporating cutting-edge technologies with high production efficiency. Rising consumer acceptance and continuous product innovation will further ensure the growth of the Recombinant Cell Culture Supplements and supplements market in the coming years.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

North America Recombinant Cell Culture Supplements Market Segmented By Product (Recombinant Albumin, Recombinant Insulin, Recombinant Epidermal Growth Factors, Recombinant Transferrin, Recombinant Trypsin, Others), By Application (Regenerative Medicine & Bio-Production), By Expression System (Mammalian Expression System, E.Coli Expression System, Yeast Expression System, Others), By End-User (Academic & Research Institutions, Biotechnology & Pharmaceutical Companies, Others), By Country, Competition, Forecast & Opportunities, 2018-2028”, has evaluated the future growth potential of North America Recombinant Cell Culture Supplements Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in North America Recombinant Cell Culture Supplements Market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com

Relevant News